Valuation: Danaher Corporation

Market Cap 163B 148B 137B 124B 233B 15,400B 241B 1,645B 652B 8,226B 613B 600B 26,113B P/E 2026 *
37x
P/E 2027 * 31x
Enterprise Value 184B 167B 154B 139B 262B 17,341B 271B 1,852B 734B 9,263B 690B 676B 29,403B EV / Sales 2026 *
7x
EV / Sales 2027 * 6.34x
Free-Float
70.56%
Yield 2026 *
0.62%
Yield 2027 * 0.68%
1 day+0.37%
1 week+2.95%
Current month+0.34%
1 month+5.34%
3 months+13.23%
6 months+40.15%
Current year+1.79%
1 week 228.37
Extreme 228.37
237.95
1 month 217.55
Extreme 217.55
238.46
Current year 160.93
Extreme 160.93
242.8
1 year 160.93
Extreme 160.93
242.8
3 years 160.93
Extreme 160.93
281.7
5 years 160.93
Extreme 160.93
331.68
10 years 76.27
Extreme 76.27
333.96
Manager TitleAgeSince
Chief Executive Officer - 01/10/2026
Director of Finance/CFO - 28/02/2026
Chief Tech/Sci/R&D Officer - 25/08/2025
Director TitleAgeSince
Director/Board Member 74 01/07/1999
Chairman 74 01/01/1984
Director/Board Member 69 01/01/1984
Date Insider Type Main position Quantity % Market Cap. Importance
30/10/26 Free

Director

13 0.0000%
30/10/26 Free

Director

193 0.0000%
30/10/26 Free

Director

144 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.37%+2.95%+6.21%+18.28% 163B
+0.11%+3.44%+19.08%+56.15% 259B
+0.84%-5.32%-22.51%+59.86% 152B
+0.32%-0.67%-57.42%-14.00% 64.07B
+1.28%+6.28%+25.20%+66.87% 60.84B
+0.34%-2.33%-1.94%-7.69% 53.91B
+0.55%+1.27%+14.81%+60.38% 48.78B
-0.29%-2.76%+1.54%+82.66% 48.96B
-0.42%+1.58%+18.81%+79.84% 45.43B
+1.44%-0.87%+10.72%+19.42% 37B
Average +0.45%+0.06%+1.45%+42.18% 93B
Weighted average by Cap. +0.41%+0.49%+2.49%+43.64%

Financials

2026 *2027 *
Net sales 26.26B 23.8B 22.01B 19.86B 37.43B 2,476B 38.75B 264B 105B 1,323B 98.55B 96.46B 4,199B 28.28B 25.63B 23.71B 21.39B 40.31B 2,667B 41.73B 285B 113B 1,425B 106B 104B 4,522B
Net income 4.4B 3.98B 3.68B 3.32B 6.27B 415B 6.49B 44.27B 17.55B 221B 16.5B 16.15B 703B 5.22B 4.73B 4.37B 3.94B 7.43B 492B 7.69B 52.51B 20.82B 263B 19.57B 19.16B 834B
Net Debt 20.58B 18.65B 17.25B 15.56B 29.33B 1,940B 30.36B 207B 82.16B 1,036B 77.22B 75.59B 3,290B 16.09B 14.58B 13.48B 12.16B 22.92B 1,517B 23.73B 162B 64.22B 810B 60.36B 59.08B 2,572B
Projected Income Statement - Annual - Danaher Corporation
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
13/11/26 US$233.02 +0.37% 3,341,085
12/11/26 US$232.16 -1.34% 2,382,361
11/11/26 US$235.31 -0.34% 3,228,140
10/11/26 US$236.11 +0.42% 3,396,149
09/11/26 US$235.12 +2.12% 3,630,575
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Danaher Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
233.02USD
Average target price
259.90USD
Spread / Average Target
+11.54%